The "disease screening pill," developed by researchers from the University of Michigan, lit up malignant tumors in mice when exposed to near-infrared light—all without the use of radiation, according to a study published in Molecular Pharmaceutics.

On May 17, the Society of Nuclear Medicine and Molecular Imaging (SNMMI) announced the Value Initiative Industry Alliance—a collaboration among corporate community members that will help implement the organization’s Value Initiative and advance nuclear medicine.

Only two percent of heavy smokers—those who smoke a pack a day—in the U.S. currently receive lung cancer screenings, according to a recent press release from the American Society of Clinical Oncology (ASCO).

The country's first "no compression" breast imaging unit opened May 16 at the Knoxville Comprehensive Breast Center (KCBC) in Tennessee, according to WFMYNews2 in Greensboro, North Carolina.

In 2005, just 27 percent of men under 65 passed on immediate therapy and instead opted for “watchful waiting” or “active surveillance” for low-risk prostate cancer. A decade later, in 2015, 72 percent decided on a more conservative approach, according to a JAMA study.

First lady Melania Trump, 48, benefited from a run-in with interventional radiology Monday morning after undergoing surgery for a benign kidney condition, according to a statement from the White House.

A combination of positive results of flutemetamol F 18–labeled PET data, low hippocampal volume and cognitive status is associated with a higher risk of progression from amnestic mild cognitive impairment (aMCI) to Alzheimer's disease within three years.

A prospective comparison study of two PET tracers found 18F-FDG could provide valuable measures of activity in bone-dominant (BD) metastatic breast cancer (MBC) patients, while also predicting responses to therapy.